Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Spindler

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Acta Oncologica (Stockholm, Sweden)|November 30, 2021
Management of late adverse effects after chemoradiation for anal cancerSusanne Haas, Anette H Mikkelsen, Camilla Kronborg, et al.
Journal of Cancer Research and Clinical Oncology|November 12, 2009
The importance of -460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancerTorben F Hansen, Karen-Lise G Spindler, Karen A Lorentzen, et al.
Acta Oncologica (Stockholm, Sweden)|March 22, 2013
Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: outcome and results of KRAS mutational analysis in plasmaKaren-Lise G Spindler, Morten M Sorensen, Niels Pallisgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2018
Prospective evaluation of acute toxicity and patient reported outcomes in anal cancer and plan optimizationCamilla Kronborg, Eva Serup-Hansen, Anna Lefevre, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 2025
Hypoxia-induced radioresistance in squamous cell carcinoma of the anus treated with radiotherapy - a validating studyKaren L Wind, Jan Alsner, Søren P Krag, et al.
Nuclear Medicine Communications|December 1, 2012
Tumour hypoxia imaging with 18F-fluoroazomycinarabinofuranoside PET/CT in patients with locally advanced rectal cancerBirgitte M Havelund, Paw C Holdgaard, Søren R Rafaelsen, et al.
Clinical and Translational Radiation Oncology|October 25, 2019
Pelvic insufficiency fractures, dose volume parameters and plan optimization after radiotherapy for rectal cancerCamilla J S Kronborg, Jesper B Jørgensen, Jørgen B B Petersen, et al.
Critical Reviews in Oncology/Hematology|February 22, 2026
Prognostic Significance of Circulating Tumor DNA as a baseline or dynamic factor in advanced NSCLC without oncogenic drivers: A Systematic Review and Meta-AnalysisM E Andersen, E M Hedegaard, S W C Wen, et al.
Acta Oncologica (Stockholm, Sweden)|January 3, 2025
The clinical utility of circulating human papillomavirus across squamous cell carcinomasKaren-Lise G Spindler, Anne V Jakobsen, Jesper G Eriksen, et al.
Physics and Imaging in Radiation Oncology|September 17, 2024
Inter-fraction motion robustness in a prospective phase II trial on dose-escalated proton reirradiation for locally recurrent rectal cancerC G Truelsen, H S Rønde, J F Kallehauge, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Acta Oncologica (Stockholm, Sweden)|November 30, 2021
Management of late adverse effects after chemoradiation for anal cancerSusanne Haas, Anette H Mikkelsen, Camilla Kronborg, et al.
Journal of Cancer Research and Clinical Oncology|November 12, 2009
The importance of -460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancerTorben F Hansen, Karen-Lise G Spindler, Karen A Lorentzen, et al.
Acta Oncologica (Stockholm, Sweden)|March 22, 2013
Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: outcome and results of KRAS mutational analysis in plasmaKaren-Lise G Spindler, Morten M Sorensen, Niels Pallisgaard, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 23, 2018
Prospective evaluation of acute toxicity and patient reported outcomes in anal cancer and plan optimizationCamilla Kronborg, Eva Serup-Hansen, Anna Lefevre, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 2025
Hypoxia-induced radioresistance in squamous cell carcinoma of the anus treated with radiotherapy - a validating studyKaren L Wind, Jan Alsner, Søren P Krag, et al.
Nuclear Medicine Communications|December 1, 2012
Tumour hypoxia imaging with 18F-fluoroazomycinarabinofuranoside PET/CT in patients with locally advanced rectal cancerBirgitte M Havelund, Paw C Holdgaard, Søren R Rafaelsen, et al.
Clinical and Translational Radiation Oncology|October 25, 2019
Pelvic insufficiency fractures, dose volume parameters and plan optimization after radiotherapy for rectal cancerCamilla J S Kronborg, Jesper B Jørgensen, Jørgen B B Petersen, et al.
Critical Reviews in Oncology/Hematology|February 22, 2026
Prognostic Significance of Circulating Tumor DNA as a baseline or dynamic factor in advanced NSCLC without oncogenic drivers: A Systematic Review and Meta-AnalysisM E Andersen, E M Hedegaard, S W C Wen, et al.
Acta Oncologica (Stockholm, Sweden)|January 3, 2025
The clinical utility of circulating human papillomavirus across squamous cell carcinomasKaren-Lise G Spindler, Anne V Jakobsen, Jesper G Eriksen, et al.
Physics and Imaging in Radiation Oncology|September 17, 2024
Inter-fraction motion robustness in a prospective phase II trial on dose-escalated proton reirradiation for locally recurrent rectal cancerC G Truelsen, H S Rønde, J F Kallehauge, et al.
Pageof 5